BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9564854)

  • 1. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
    Hulley PA; Gordon F; Hough FS
    Endocrinology; 1998 May; 139(5):2423-31. PubMed ID: 9564854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification and characterization of an enzyme from pea nuclei with protein tyrosine phosphatase activity.
    Guo YL; Roux SJ
    Plant Physiol; 1995 Jan; 107(1):167-75. PubMed ID: 11536662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting phosphatases: From molecule design to clinical trials.
    Guo M; Li Z; Gu M; Gu J; You Q; Wang L
    Eur J Med Chem; 2024 Jan; 264():116031. PubMed ID: 38101039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.
    Gado M; Baschant U; Hofbauer LC; Henneicke H
    Front Endocrinol (Lausanne); 2022; 13():835720. PubMed ID: 35432217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of small G protein RhoB in the regulation of proliferation, adhesion and migration by dexamethasone in osteoblastic cells.
    Diao F; Chen K; Wang Y; Li Y; Xu W; Lu J; Chen YX
    PLoS One; 2017; 12(3):e0174273. PubMed ID: 28323887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-Osteoblasts.
    Sanderson M; Sadie-Van Gijsen H; Hough S; Ferris WF
    PLoS One; 2015; 10(8):e0135358. PubMed ID: 26263165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-Induced Osteoporosis.
    Frenkel B; White W; Tuckermann J
    Adv Exp Med Biol; 2015; 872():179-215. PubMed ID: 26215995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortalized Mouse Floxed Fam20c Dental Papillar Mesenchymal and Osteoblast Cell Lines Retain Their Primary Characteristics.
    Liu C; Wang X; Zhang H; Xie X; Liu P; Liu Y; Jani PH; Lu Y; Chen S; Qin C
    J Cell Physiol; 2015 Nov; 230(11):2581-7. PubMed ID: 25833681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.
    Jain A; Wordinger RJ; Yorio T; Clark AF
    J Ocul Pharmacol Ther; 2014; 30(2-3):121-7. PubMed ID: 24506296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of glucocorticoid-induced leucine zipper (GILZ) in cardiomyocytes.
    Aguilar DC; Strom J; Xu B; Kappeler K; Chen QM
    Cardiovasc Toxicol; 2013 Jun; 13(2):91-9. PubMed ID: 23090754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.
    Ma Y; Nyman JS; Tao H; Moss HH; Yang X; Elefteriou F
    Endocrinology; 2011 Apr; 152(4):1412-22. PubMed ID: 21266510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
    Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
    Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.
    Espina B; Liang M; Russell RG; Hulley PA
    J Cell Physiol; 2008 May; 215(2):488-96. PubMed ID: 18064628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo.
    Conradie MM; de Wet H; Kotze DD; Burrin JM; Hough FS; Hulley PA
    J Endocrinol; 2007 Nov; 195(2):229-40. PubMed ID: 17951534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
    Horsch K; de Wet H; Schuurmans MM; Allie-Reid F; Cato AC; Cunningham J; Burrin JM; Hough FS; Hulley PA
    Mol Endocrinol; 2007 Dec; 21(12):2929-40. PubMed ID: 17761948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction with the importin-alpha nuclear import protein.
    Buse P; Maiyar AC; Failor KL; Tran S; Leong ML; Firestone GL
    Exp Cell Res; 2007 Sep; 313(15):3261-75. PubMed ID: 17692313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development.
    James CG; Ulici V; Tuckermann J; Underhill TM; Beier F
    BMC Genomics; 2007 Jul; 8():205. PubMed ID: 17603917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells.
    Sakai A; Han J; Cato AC; Akira S; Li JD
    BMC Mol Biol; 2004 May; 5():2. PubMed ID: 15125785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.
    Engelbrecht Y; de Wet H; Horsch K; Langeveldt CR; Hough FS; Hulley PA
    Endocrinology; 2003 Feb; 144(2):412-22. PubMed ID: 12538600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.
    Lasa M; Abraham SM; Boucheron C; Saklatvala J; Clark AR
    Mol Cell Biol; 2002 Nov; 22(22):7802-11. PubMed ID: 12391149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.